NYC’s top re­search in­sti­tu­tions part­ner on Step 2 in build­ing a biotech hub

A trio of New York’s best known re­search in­sti­tu­tions have al­lied with Take­da and a pair of biotech in­vestors to start up a new com­pa­ny that will car­ry some promis­ing new pro­grams in­to clin­i­cal de­vel­op­ment.

Memo­r­i­al Sloan Ket­ter­ing Can­cer Cen­ter, The Rock­e­feller Uni­ver­si­ty and Weill Cor­nell Med­i­cine part­nered with the re­struc­tur­ing Take­da along with Bay City Cap­i­tal and Deer­field Man­age­ment to cre­ate Bridge Med­i­cines.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.